0.5035
price down icon1.07%   -0.0055
 
loading
BiomX Inc stock is traded at $0.5035, with a volume of 69,908. It is down -1.07% in the last 24 hours and down -47.67% over the past month. BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.509
Open:
$0.511
24h Volume:
69,908
Relative Volume:
0.78
Market Cap:
$9.60M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.6713
EPS:
-0.75
Net Cash Flow:
$-22.29M
1W Performance:
-32.86%
1M Performance:
-47.67%
6M Performance:
-86.20%
1Y Performance:
-87.40%
1-Day Range:
Value
$0.5035
$0.544
1-Week Range:
Value
$0.5036
$0.77
52-Week Range:
Value
$0.5036
$8.55

BiomX Inc Stock (PHGE) Company Profile

Name
Name
BiomX Inc
Name
Phone
972 7 23942377
Name
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Name
Employee
73
Name
Twitter
@BiomX_Inc
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
PHGE's Discussions on Twitter

Compare PHGE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
PHGE 0.5035 9.60M 0 -26.56M -22.29M -0.75
VRTX 447.32 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.21 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.97 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.16 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.92 24.49B 3.30B -501.07M 1.03B 11.54

BiomX Inc Stock (PHGE) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-15-21 Initiated Ladenburg Thalmann Buy

BiomX Inc Stock (PHGE) Latest News

pulisher
Nov 20, 2024

BiomX (PHGE) 5-Day RSI : 13.43 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 16, 2024

BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire

Nov 12, 2024
pulisher
Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India

Nov 01, 2024
pulisher
Oct 25, 2024

Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat

Oct 23, 2024
pulisher
Oct 19, 2024

BiomX announces a mandatory unit separation - MSN

Oct 19, 2024
pulisher
Oct 16, 2024

BiomX announces mandatory unit separation - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

BiomX Announces a Mandatory Unit Separation - The Manila Times

Oct 15, 2024
pulisher
Oct 09, 2024

BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 05, 2024

BiomX (NYSEAMERICAN:PHGE) Shares Down 1.5% – What’s Next? - Defense World

Oct 05, 2024
pulisher
Oct 03, 2024

Biomx stock plunges to 52-week low, hitting $0.92 - Investing.com

Oct 03, 2024
pulisher
Oct 03, 2024

Biomx stock plunges to 52-week low, hitting $0.92 By Investing.com - Investing.com South Africa

Oct 03, 2024
pulisher
Oct 02, 2024

BiomX (NYSEMKT:PHGE) Stock Price Down 1% - Defense World

Oct 02, 2024
pulisher
Sep 26, 2024

BiomX Shares Phage Therapy Advances and Vision - TipRanks

Sep 26, 2024
pulisher
Sep 26, 2024

Bacteriophages Therapy Market Size, Share And Growth Analysis - openPR

Sep 26, 2024
pulisher
Sep 20, 2024

BiomX Stock Gains From Favorable Study Data Presentation on BX004 - Yahoo Finance

Sep 20, 2024
pulisher
Sep 18, 2024

BiomX to present data from Phase 1b/2a study of BX004 - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

BiomX to Provide Latest Update on Positive Phase 1b/2a - GlobeNewswire

Sep 18, 2024
pulisher
Sep 18, 2024

BiomX to Provide Latest Update on Positive Phase 1b/2a Clinical Trial Data for BX004 at the North American Cystic Fibrosis Conference - StockTitan

Sep 18, 2024
pulisher
Sep 11, 2024

Biomx stock plunges to 52-week low, hits $1.05 - Investing.com

Sep 11, 2024
pulisher
Sep 10, 2024

BiomX (NYSEMKT:PHGE) Trading Down 5.4% - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

BiomX (NYSEMKT:PHGE) Shares Down 5.4% - Defense World

Sep 10, 2024
pulisher
Sep 06, 2024

Bacteriophage Therapy Market Projected To Witness Substantial Growth, 2024-2031: Enbiotix, Inc., Nextbiotics, - EIN News

Sep 06, 2024
pulisher
Sep 04, 2024

BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 04, 2024
pulisher
Sep 04, 2024

PHGEBiomX Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Biomx stock plunges to 52-week low at $1.15 amid market challenges - Investing.com

Sep 04, 2024
pulisher
Sep 03, 2024

BiomX to Present Positive Phase 1b/2a Clinical Trial Data - GlobeNewswire

Sep 03, 2024
pulisher
Sep 03, 2024

BiomX to present cinical trial data for BX004 at ERS - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024 - StockTitan

Sep 03, 2024
pulisher
Aug 27, 2024

Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Drops By 92.9% - MarketBeat

Aug 27, 2024
pulisher
Aug 26, 2024

BiomX Inc (PHGE) stock analysis: A comprehensive overview - US Post News

Aug 26, 2024
pulisher
Aug 22, 2024

Biomx stock plunges to 52-week low at $0.14 amid market challenges - Investing.com

Aug 22, 2024
pulisher
Aug 21, 2024

There is no doubt that BiomX Inc (PHGE) ticks all the boxes. - SETE News

Aug 21, 2024
pulisher
Aug 20, 2024

PHGE’s 2023 Market Dance: Down -44.29% – Time to Invest? - The InvestChronicle

Aug 20, 2024
pulisher
Aug 20, 2024

Balance Sheet Insights: BiomX Inc (PHGE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Aug 20, 2024
pulisher
Aug 19, 2024

BiomX Inc (PHGE)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Aug 19, 2024

BiomX Inc Stock (PHGE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):